Policy / Pricing FDA floats new clinical trial reforms; Takeda punts Denali brain drug BioPharma DiveIn its budget request, the agency proposed a way to speed up early drug testing and help smaller biotech firms.Policy / PricingRead full story pharminent April 6, 2026 (Last updated: April 6, 2026) BioPharma Dive In its budget request, the agency proposed a way to speed up early drug testing and help smaller biotech firms. Policy / PricingRead full story Post navigation Previous: Neurocrine to acquire Prader-Will drug in $2.9B Soleno buyoutNext: Amgen scores with new thyroid eye disease formulation Related Stories Policy / Pricing Mid-cap biotechs join Trump’s latest round of drug pricing deals pharminent September 1, 2026 Policy / Pricing MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones pharminent August 27, 2026 Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026